Phase 2 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with type 2 diabetes and are currently receiving medication or making lifestyle changes to manage their blood sugar levels.
- People whose HbA1c (a blood test that shows average blood sugar levels over the past few months) is between 6.5% and 10% at the time of screening.
- People whose kidneys are working at a reduced but not severely low level, as measured by a specific kidney function test called eGFR, with a result between 30 and 90 at screening (confirm with trial site).
- People who have a moderately to severely elevated level of a protein called albumin in their urine, measured by a specific ratio (UACR) between 500 and 5000 mg/g at screening.
Who may not be able to join:
- People who have kidney disease that is not caused by their diabetes.
- People whose kidney disease required treatment with strong immune-suppressing medications, or who have previously had dialysis or a kidney transplant.
- People whose overall health is considered unstable by the doctor running the trial.
- People who have been admitted to hospital for more than 24 hours within the 30 days before their screening visit.
Important: This trial has additional eligibility criteria not listed here. Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trial Management, Regeneron Pharmaceuticals
Phone: 844-734-6643
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percent change in Urine Albumin to Creatinine Ratio (UACR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.